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ther et al., but the low TGF-β response in cases of se-
vere malaria (who also had the highest parasite bur-
dens) are likely to represent a failure of the regulatory
response to dampen host pathology late in infection.
Understanding the nature of the TGF-β response
throughout infection should yield important insights
into immunity and pathogenesis.
The paper raises many questions relevant to patho-
genesis. Foremost is why only some individuals gener-
ate a TGF-β response and whether such individuals
would ultimately demonstrate a worse outcome (had
the infection been allowed to proceed). The authors
suggest a genetic basis for the variation in response,
but their data do not exclude that the response is
stochastic. This could be explored by reexposing the
same individuals to another infection and observing
whether the same TGF-β response followed. Identifica-
tion of the parasite molecule(s) responsible for stimulat-
ing TGF-β production is an important challenge and
could lead to novel therapies relevant not only to ma-
laria but to many diseases. It is also important to iden-
tify the source of TGF-β. While their data point to
monocytes as a likely source within peripheral blood,
non-blood cells such as hepatocytes cannot be ex-
cluded, particularly since infection commenced with a
sporozoite inoculation, which is immediately followed
by a liver phase. It is also not clear whether TGF-β
transformed conventional CD4+ T cells to become T
regs (Chen et al., 2003) or whether natural T reg cells
are activated by Plasmodium to produce TGF-β.
The demonstration of a correlation between early
parasite growth rates and parameters of immune regu-
lance of malaria that will be invaluable for vaccine and
possibly drug development to combat malaria.
Michael F. Good
The Queensland Institute of Medical Research
P.O. Royal Brisbane Hospital
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but Does Antigen Bade B Cells
to Take the Road Less Traveled?
The contribution of a self-antigen to marginal-zone B
lymphocytes is described in this issue (Wen et al.,
2005). Other interpretations of these important find-
ings are considered here.
The development of B and T lymphocytes stands apart
from that of most other cellular lineages primarily be-
cause of the need for antigen-receptor diversification
in lymphocytes and the consequent requirement for de-
velopmental checkpoints based on the reading frame
of rearranged genes and the recognition of self. It is
well established that T cells are positively selected by
low-avidity MHC-peptide complexes, but the existence
of an analogous phenomenon in B cells has remained
a subject of debate. The BCR is required for B cell de-
velopment (Lam et al., 1997; Kraus et al., 2004) and may
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asignal constitutively in an antigen-independent mannerTze et al., 2005). A potential rationale for the positive
election of B lymphocytes is the presumed ability of
elf-antigens possessing different avidities for clonal
ntigen receptors to provide distinct instructive signals
hat commit developing cells to separate peripheral B
ell lineages. If the BCR were only required for develop-
ental progression or survival, but not for lineage com-
itment, stereotypic constitutive BCR signaling would
heoretically be all that is required. Several pieces of
vidence have argued that B cells may be positively
elected by self-antigen and that the BCR may also
ontribute to the initiation of lineage commitment dur-
ng B lymphocyte maturation (Pillai, 1999; Pillai et al.,
005).
In a landmark study, the expression of Thy-1 as a
elf-antigen was shown to be required for the develop-
ent of peritoneal CD5+ B-1a B cells that express Ig
ransgenes specific for a carbohydrate epitope on this
lycosylphosphatidylinositol-anchored cell-surface
lycoprotein (Hayakawa et al., 1999). Most B-1a B cells
riginate from fetal liver stem cells, and it was originally
ssumed that positive selection might not be required
for the development of conventional B cells. Conven-
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243tional IgDhiIgMlo mature follicular B cells, like B-1 B
cells, require the TEC family kinase, Btk, for their sur-
vival or development. A number of mutant mice defi-
cient in inhibitors of BCR/Btk signaling display en-
hanced BCR signal strength and the loss of splenic
marginal zone (MZ) B cells but not of IgDhiIgMlo mature
follicular B cells (Cariappa et al., 2001; reviewed in Pillai
et al., 2005). The possibility has therefore been raised
that weak interactions of developing B cells with self-
antigens facilitates differentiation into the MZ B cell
pool and could allow these cells to respond to other
inductive signals, at the very least involving Notch2 and
NFκB1 (Cariappa et al., 2000; Saito et al., 2003). More
avid interactions of developing B cells with self-antigen
have been postulated to facilitate Btk-dependent differ-
entiation into IgDhiIgMlo mature follicular B cells (Pillai
et al., 2005).
In this issue Hayakawa and coworkers (Wen et al.,
2005) provide compelling evidence for the role of self-
antigen in MZ B cell generation. This study is of con-
siderable interest because it provides direct evidence
for antigen-influenced splenic B cell development. It is
particularly intriguing because it appears to suggest
that mature follicular B cell generation represents a
“default” fate and that self-antigen drives the preferen-
tial development of MZ B cells, in apparent contradic-
tion to conclusions made from a number of previous
studies. The development of Thy-1-specific BCR ex-
pressing B cells was analyzed in a wild-type back-
ground, in the context of the total absence of Thy-1, or
in a Rag-1 null background. In the presence of Thy-1,
the majority of splenic B cells were short-lived CD24hi
CD21lo immature/transitional B cells. A small number of
CD24loCD21int follicular B cells were also observed, but
few if any CD21hi MZ B cells were seen. In the total
absence of Thy-1, some immature/transitional B cells
and substantial numbers of CD24loCD21int follicular B
cells were detected in the spleen, but once again few
MZ B cells were observed. When the transgenic BCR
was expressed in Rag-1 null mice (in which Thy-1 is
presumably expressed primarily in neurons and thymic
pro-T cells), anti-Thy-1 B cells were seen in the imma-
ture/transitional and MZ B cell compartments but were
barely detectable in the follicular B cell compartment.
How exactly and in what form Thy-1 that is expressed
in relatively sequestered sites in Rag-1 null mice is
made available to developing B cells is unclear. The
authors make the tacit assumption that in Thy-1 null
mice no cross-reactive self-antigens recognize the anti-
Thy-1 BCR, even with low affinity. They conclude that
in the absence of self-antigen, B cells assume a default
mature-follicular-B-cell fate and that in the Rag-1 null
background smaller amounts of a poorly characterized
version of the Thy-1 antigen drive MZ B cell devel-
opment.
These results are striking and certainly thought pro-
voking. At least two other interpretations of the data
are worth exploring for a number of reasons. There are
some limitations to using a transgenic model of this
sort when studying peripheral B cells. The inability to
use surface IgD as a marker compromises the ability to
adequately resolve the heterogeneity of follicular B
cells and raises an obvious “apples and oranges” con-
cern. There is growing evidence to suggest the exis-
tence of “posttransitional” long-lived Btk-independentfollicular B cells that are distinct from mature follicular
B cells. The former may represent a circulating reservoir
of cells capable of being drawn into the MZ or mature-
follicular-B-cell pools (discussed in Pillai et al., 2005).
One alternative interpretation of the data is that the
CD24lo cells that accumulate in the total absence of
Thy-1 represent Btk-independent posttransitional follic-
ular B cells and not mature follicular B cells. This type
of transgenic model does not unambiguously establish
that mature follicular B cells occupy a “default” com-
partment. In a Rag-1 null background some form of the
Thy-1 N-linked glycan epitope, presumably cleaved
from the surface of pro-T cells or neurons by a phos-
phatidylinositol-phospholipase C and perhaps pro-
cessed by additional proteases and glycosidases in the
circulation, drives developing anti-Thy-1 B cells effi-
ciently into the MZ B cell compartment. A cleaved form
of Thy-1 may provide relatively weak BCR signals that
in turn strongly favor MZ B cell development. There are
no data presented by Wen et al. that directly address
or refute this possibility.
Lacking a stringent demonstration of IgDhiIgMlo ma-
ture-follicular-B-cell development in the absence of
Thy-1, alternative interpretations postulating a role for
unidentified self-antigens may well be considered su-
perfluous. However, establishing the “total absence” of
a cross-reacting self-antigen for any B lymphocyte is a
tall order. A second alternative scenario to consider in
this particular transgenic model is that in the total ab-
sence of Thy-1, an unidentified multivalent self-antigen
might drive B cells expressing this specific BCR
towards the mature-follicular-B-cell compartment (al-
though the precise categorization of the follicular B
cells in this model remains ambiguous). In Rag-1
knockout mice, relatively high concentrations of a pau-
civalent, monovalent, or fragmented form of Thy-1 may
competitively inhibit this putative, unidentified self-anti-
gen, thus permitting B cells to be driven by relatively
weak BCR signals and Notch2 to assume a marginal-
zone B cell fate.
There is no reason, in the absence of more specific
information and based on the results presented, to nec-
essarily favor one of the above scenarios over the
model posited in this extremely interesting and provoc-
ative report. However, many other existing pieces of the
puzzle may more readily fit these alternative inter-
pretations. Clearly, these workers and others in the field
will want to revisit these issues by employing ap-
proaches that permit a more complete analysis of sple-
nic B cell populations.
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